SCHEMBL24665376

SCHEMBL24665376

N[C@H](CO)Cc1nc(-c2cccc(Oc3ccc(OC(F)F)cn3)c2)no1

nearest known ligand 0.56

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ LTA4H P09960 2/20 0.56
▸ KCNH2 Q12809 1/20 0.51
▸ FFAR1 O14842 5/20 0.38
▸ SCN9A Q15858 2/20 0.38
▸ MAPT P10636 3/20 0.38
▸ SMN1; SMN2 Q16637 3/20 0.36
▸ SCN10A Q9Y5Y9 2/20 0.35
▸ NPC1 O15118 2/20 0.35
▸ RAB9A P51151 2/20 0.35
▸ TDP1 Q9NUW8 2/20 0.35
▸ MAPK1 P28482 1/20 0.35
▸ L3MBTL1 Q9Y468 1/20 0.35
▸ THRB P10828 1/20 0.34
▸ SCN5A Q14524 1/20 0.33
▸ CDK2 P24941 1/20 0.33
▸ AKT1 P31749 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29123411 1.00 LTA4H (0.56) LTA4HKCNH2FFAR1SCN9AMAPT
SCHEMBL27204783 0.90 LTA4H (0.68) LTA4HKCNH2FFAR1SCN9AMAPT
SCHEMBL27171420 0.90 LTA4H (0.68) LTA4HKCNH2FFAR1SCN9AMAPT
SCHEMBL29123726 0.86 LTA4H (0.42) LTA4HKCNH2FFAR1SCN9AMAPT
SCHEMBL29123730 0.86 LTA4H (0.42) LTA4HKCNH2FFAR1SCN9AMAPT
SCHEMBL27204649 0.86 LTA4H (0.58) LTA4HKCNH2FFAR1MAPTSMN1; SMN2
SCHEMBL24665357 0.86 LTA4H (0.58) LTA4HKCNH2FFAR1MAPTSMN1; SMN2
SCHEMBL29123324 0.85 LTA4H (0.54) LTA4HKCNH2FFAR1SCN9AMAPT
SCHEMBL24664170 0.85 LTA4H (0.54) LTA4HKCNH2FFAR1SCN9AMAPT
SCHEMBL27243633 0.85 LTA4H (0.40) LTA4HKCNH2FFAR1SCN9AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4323062-B1 HETEROARYL AMINOPROPANOL DERIVATIVES AS INHIBITORS OF LTA4H NOVARTIS AG (CH) 2025-07-23 — — EP claimed
EP-4323062-A1 HETEROARYL AMINOPROPANOL DERIVATIVES AS INHIBITORS OF LTA4H Novartis AG (CH) 2024-02-21 — — EP claimed
CN-117015537-A Heteroaryl aminopropanol derivatives as inhibitors of LTA4H 诺华股份有限公司 2023-11-07 — — CN claimed
WO-2022219546-A1 HETEROARYL AMINOPROPANOL DERIVATIVES AS INHIBITORS OF LTA4H NOVARTIS AG (CH) 2022-10-20 — — WO claimed
EP-4323062-A1 HETEROARYL AMINOPROPANOL DERIVATIVES AS INHIBITORS OF LTA4H Novartis AG (CH) 2024-02-21 — — EP disclosed
CN-117015537-A Heteroaryl aminopropanol derivatives as inhibitors of LTA4H 诺华股份有限公司 2023-11-07 — — CN disclosed
WO-2022219546-A1 HETEROARYL AMINOPROPANOL DERIVATIVES AS INHIBITORS OF LTA4H NOVARTIS AG (CH) 2022-10-20 — — WO disclosed
WO-2022219546-A1 HETEROARYL AMINOPROPANOL DERIVATIVES AS INHIBITORS OF LTA4H NOVARTIS AG (CH) 2022-10-20 — — WO disclosed
Send feedback